Solasia Pharma KK
TSE:4597
Solasia Pharma KK
Depreciation & Amortization
Solasia Pharma KK
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Solasia Pharma KK
TSE:4597
|
Depreciation & Amortization
¥467m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Depreciation & Amortization
¥671.8m
|
CAGR 3-Years
25%
|
CAGR 5-Years
32%
|
CAGR 10-Years
34%
|
|
PeptiDream Inc
TSE:4587
|
Depreciation & Amortization
¥2.4B
|
CAGR 3-Years
62%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Depreciation & Amortization
¥4.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Depreciation & Amortization
¥134m
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
S
|
StemRIM Inc
TSE:4599
|
Depreciation & Amortization
¥47.8m
|
CAGR 3-Years
84%
|
CAGR 5-Years
112%
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Depreciation & Amortization?
Depreciation & Amortization
467m
JPY
Based on the financial report for Mar 31, 2024, Solasia Pharma KK's Depreciation & Amortization amounts to 467m JPY.
What is Solasia Pharma KK's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
12%
Over the last year, the Depreciation & Amortization growth was -13%. The average annual Depreciation & Amortization growth rates for Solasia Pharma KK have been -2% over the past three years , 12% over the past five years .